These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39257124)

  • 1. A Rare Case of X-Linked Four-Way Philadelphia Chromosome Translocation with Therapeutic Challenges and Clonal Evolution.
    Park SE; Lee JK; Kang HJ; Hong YJ; Oh AC; Kim H
    Clin Lab; 2024 Sep; 70(9):. PubMed ID: 39257124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene.
    Okada M; Satake A; Kaida K; Taniguchi K; Yoshihara S; Ikegame K; Tamaki H; Soma T; Fujimori Y; Ogawa H
    Int J Hematol; 2011 Feb; 93(2):243-246. PubMed ID: 21279819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of clinical and genetic features of CML patients with variant Philadelphia translocations involving chromosome 7: A case series.
    Bayrak AG; Daglar Aday A; Yavuz AS; Nalcaci M; Ozbalak MM; Cefle K; Ozturk S; Palanduz S
    Leuk Res; 2021 Dec; 111():106725. PubMed ID: 34634595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular, Cytogenetic, and Hematological Analysis of Chronic Myeloid Leukemia Patients and Discovery of Two Novel Translocations.
    Asif M; Hussain A; Wali A; Ahmed N; Ali I; Iqbal Z; Amir M; Shafiq M; Rasool M
    Anal Cell Pathol (Amst); 2021; 2021():4909012. PubMed ID: 34422550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first case of six-way complex translocation of t(4;7;9;22;8;14) in a patient with chronic myeloid leukemia.
    Bi X; Li C; Shang M; Han B; Li H; Sun L; Lin Y; Yang S
    J Hematop; 2024 Jun; 17(2):97-101. PubMed ID: 38492169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial.
    Kantarjian HM; Hochhaus A; Saglio G; De Souza C; Flinn IW; Stenke L; Goh YT; Rosti G; Nakamae H; Gallagher NJ; Hoenekopp A; Blakesley RE; Larson RA; Hughes TP
    Lancet Oncol; 2011 Sep; 12(9):841-51. PubMed ID: 21856226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Myeloid Leukemia with a Rare Philadelphia Chromosome Variant Involving Chromosome 16.
    Bahashwan SM
    Am J Case Rep; 2024 Aug; 25():e944641. PubMed ID: 39215452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-way Philadelphia Translocation [t(46, XX, t(9;22;16) (q34;q11.2;q24)] in Chronic Myeloid Leukemia: A Report of Two Cases with Review of the Literature.
    Bhardwaj M; Mishra SK; Gupta A; Mehta P; Sharma S; Mohanty SK
    J Cancer Res Ther; 2024 Apr; 20(3):1066-1070. PubMed ID: 38261414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.
    Morel F; Bris MJ; Herry A; Calvez GL; Marion V; Abgrall JF; Berthou C; Braekeleer MD
    Eur J Haematol; 2003 Apr; 70(4):235-9. PubMed ID: 12656747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management.
    Jabbour E; Kantarjian H
    Am J Hematol; 2012 Nov; 87(11):1037-45. PubMed ID: 23090888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent chronic myeloid leukemia with t (9;22;16) (q34; q11; p13) treated by nilotinib: A case report.
    Shu Y; Yang W; Zhang X; Xu X
    Medicine (Baltimore); 2018 Oct; 97(42):e12875. PubMed ID: 30335005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring.
    Jabbour E; Kantarjian H
    Am J Hematol; 2022 Sep; 97(9):1236-1256. PubMed ID: 35751859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique three-way Philadelphia chromosome variant t(4;9;22)(q21;q34;q11.2) in a newly diagnosed patient with chronic phase chronic myeloid leukemia: a case report and review of the literature.
    Torii Y; Nanjo K; Toubai T; Hosokawa M; Sato R; Yamada A; Aizawa K; Himuro M; Ito S; Yamamoto M; Magenau J; Wilcox R; Ishizawa K
    J Med Case Rep; 2021 May; 15(1):285. PubMed ID: 34030730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia.
    Crisan AM; Coriu D; Arion C; Colita A; Jardan C
    J Med Life; 2015; 8(4):502-8. PubMed ID: 26664479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements.
    Albano F; Anelli L; Zagaria A; Coccaro N; Casieri P; Rossi AR; Vicari L; Liso V; Rocchi M; Specchia G
    Mol Cancer; 2010 May; 9():120. PubMed ID: 20500819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique case of complex variant translocation of t(6;9;22)(p22;q34;q11.2), der(19) in a newly diagnosed patient with chronic myeloid leukemia.
    Ciftciler R; Saglam EA; Inanc A; Ozcebe O; Haznedaroglu IC
    Cancer Genet; 2019 Sep; 237():78-81. PubMed ID: 31447069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.
    Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA
    Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of chronic myeloid leukemia presenting with isolated thrombocytosis and complex Philadelphia chromosome: A case report.
    Gao L; Ren MQ; Tian ZG; Peng ZY; Shi G; Yuan Z
    Medicine (Baltimore); 2021 Sep; 100(35):e27134. PubMed ID: 34477162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22).
    Tirrò E; Massimino M; Stella S; Zammit V; Consoli ML; Pennisi MS; Vitale SR; Romano C; Pirosa MC; Martino E; DI Gregorio S; Puma A; DI Raimondo F; Manzella L; Stagno F
    Anticancer Res; 2019 Jul; 39(7):3893-3899. PubMed ID: 31262918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia.
    Kim TD; Türkmen S; Schwarz M; Koca G; Nogai H; Bommer C; Dörken B; Daniel P; le Coutre P
    Haematologica; 2010 Apr; 95(4):582-8. PubMed ID: 20015884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.